美国血液学会明智选择建议发布后弥漫大B细胞淋巴瘤幸存者监测影像频率的变化
该研究利用OptumLabs全国保险理赔数据库回顾性分析2008至2016年弥漫大B细胞淋巴瘤幸存者的监测影像频率,比较ASH明智选择建议发布前后三个时段的变化。结果显示第一年和第二年监测影像率在第三时段(2014至2016年)较前两个时段下降,2012年之后是过度使用减少的显著预测因素。作者认为建议变化、报销政策和提供者知识基础等多因素可能共同起作用,需进一步研究。
要点
- 监测第一年影像率:第一时段91%、第二时段88%、第三时段78%,第三时段较前下降(P<.01)。
- 监测第二年影像率:第一时段83%、第二时段77%、第三时段61%,第三时段较前下降(P<.01)。
- 2012年之后是监测第一年过度使用(每年超过两次扫描)减少的显著预测因素(2013年 vs 2008年OR 0.49,P=.02)。
诊断标准与关键数值
- 监测第一年影像率:时段1为199例(91%),时段2为257例(88%),时段3为315例(78%);时段3较前下降(P<.01)。
- 监测第二年影像率:时段1为137例(83%),时段2为172例(77%),时段3为83例(61%);时段3较前下降(P<.01)。
- 多变量逻辑回归中,2012年之后是监测第一年过度使用(每年超过两次扫描)减少的显著预测因素:2013年 vs 2008年OR 0.49(P=.02)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In 2013, the American Society of Hematology (ASH) published recommendations with Choosing Wisely to limit surveillance imaging in aggressive lymphoma. We studied surveillance imaging practice patterns for diffuse large B-cell lymphoma (DLBCL) before and after the ASH Choosing Wisely campaign. We used OptumLabs Data Warehouse, a national insurance claims database, to retrospectively study imaging frequency in survivors of DLBCL from 2008 to 2016. Three time periods were defined: Period 1 (2008 to 2010), Period 2 (2011 to 2013), and Period 3 (2014 to 2016). One thousand four hundred seventy-two patients were included. Median follow up was approximately 2 years. During the first and second years of surveillance, imaging remained stable between Period 1 (years 1 and 2: 199 [91%] and 137 [83%], respectively) and Period 2 (years 1 and 2: 257 [88%] and 172 [77%], respectively; P = .38), but decreased in Period 3 (years 1 and 2: 315 [78%] and 83 [61%], respectively; P < .01). In a multivariable logistic regression, year after 2012 was a significant predictor of decreased overuse (more than two scans per year in the first year of surveillance; [odds ratio, 0.49 for 2013 v 2008; P = .02]). Our study demonstrated the rate of surveillance scans-both computed tomography and positron emission tomography imaging-in DLBCL decreased after the ASH Choosing Wisely campaign. Multiple factors, such as changes in recommendations, reimbursement, and provider knowledge base, may have all contributed and should be studied further.
引用
- Durani U, Asante D, Heien HC, et al. Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations. JCO Oncol Pract. 2020. PMID: 33095693. doi:10.1200/OP.20.00362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。